Author: digi

De-Risking New or Naïve Sites Without Slowing Study Timelines In the rapidly evolving landscape of clinical trials, the urgency to bring new treatments to market frequently intersects with the necessity of meticulous site selection and qualification. This tutorial provides a comprehensive step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals focused on de-risking…

Read More “De-Risking New or Naïve Sites Without Slowing Study Timelines” »

Leveraging Historical Performance Data in Site Selection Decisions Leveraging Historical Performance Data in Site Selection Decisions In the realm of clinical research, making informed decisions during the site selection process is crucial for the success of a clinical trial. The selection of sites where the study will be conducted can directly influence the quality of…

Read More “Leveraging Historical Performance Data in Site Selection Decisions” »

High-Performing Site Selection Strategies for Global Clinical Trials High-Performing Site Selection Strategies for Global Clinical Trials Effective site selection is a crucial step in the planning and execution of clinical trials. It significantly influences the success of the study, not only regarding participant enrollment rates but also in ensuring compliance with regulatory requirements, enhancing data…

Read More “High-Performing Site Selection Strategies for Global Clinical Trials” »

Feasibility-Driven Site Qualification: Metrics, Data Sources and Red Flags Feasibility-Driven Site Qualification: Metrics, Data Sources and Red Flags Site qualification is a critical phase in the process of initiating clinical trials. As clinical research becomes more complex, the need for a meticulous and data-driven approach to site selection has never been more essential. This guide…

Read More “Feasibility-Driven Site Qualification: Metrics, Data Sources and Red Flags” »

Balancing Key Opinion Leaders and High-Throughput Sites in Site Selection Balancing Key Opinion Leaders and High-Throughput Sites in Site Selection In the realm of clinical trials, the delicate balance between engaging Key Opinion Leaders (KOLs) and maximizing the efficiency of high-throughput sites is a critical aspect of site selection. This process is essential for ensuring…

Read More “Balancing Key Opinion Leaders and High-Throughput Sites in Site Selection” »

Country and Site Feasibility: Turning Early Insights Into Smart Site Lists Country and Site Feasibility: Turning Early Insights Into Smart Site Lists In the rapidly evolving landscape of clinical research, effective site selection and qualification are pivotal for the success of clinical trials. Ensuring a well-chosen cohort of sites can significantly impact patient recruitment and…

Read More “Country and Site Feasibility: Turning Early Insights Into Smart Site Lists” »

Risk-Based Site Qualification in Complex, Multi-Region Clinical Programs In the modern landscape of clinical research, conducting multi-region clinical trials necessitates a nuanced approach to site qualification. This article serves as a comprehensive tutorial guide for clinical operations, regulatory affairs, and medical affairs professionals focused on risk-based site qualification. It discusses the steps involved in ensuring…

Read More “Risk-Based Site Qualification in Complex, Multi-Region Clinical Programs” »